The overarching objective of the EUnetHTA Joint Action 1 (JA1) on Health Technology Assessment (HTA) including work on relative effectiveness of pharmaceuticals was to put into practice an effective and sustainable HTA collaboration in Europe that brought added value at the European, national and regional level. The JA brought together HTA agencies and institutional producers of HTA and assessments of pharmaceuticals across Europe. The JA1 facilitated solutions to overcome barriers to collaboration and made it possible to deliver context specific reporting of HTA results.
The strategic objectives of the JA1 were:
-To develop principles, methodological guidance as well as functional online tools and policies for
-To test and implement
See the Technical Annex of the JA1 Grant Agreement with the Commission
EUnetHTA JA1 (2010-2012) Final Technical Report
KCE (Belgium) , DHMA (Denmark) , HAS (EUnetHTA Assembly) , KCE (EUnetHTA Assembly) , THL (EUnetHTA Assembly) , ZIN (EUnetHTA Assembly) , HAS (Executive Board) , KCE (Executive Board) , ZIN (Executive Board) , THL (Finland)
Agenas (EUnetHTA Assembly) , Agenas (Executive Board) , Agenas (Founding Partner) , Agenas (Italy) , Agenas (Partner)
JA WP1 – CoordinationJA WP2 – DisseminationJA WP3 – EvaluationJA WP4 – Core HTAJA WP5 – Relative Effectiveness Assessment of PharmaceuticalsJA WP6 – Information Management SystemJA WP7 – New TechnologiesJA WP8 – Strategy and Business Model Development
Please see below the policy and procedures guiding stakeholder involvement activities in the EUnetHTA Joint Action 1. The documents were a result of an extensive development process that were managed by the Executive Committee. It involved consultation with multiple interested parties including a public consultation and several rounds of review by the EUnetHTA Joint Action Plenary Assembly and the Stakeholder Forum.
EUnetHTA JA Stakeholder Involvement Policy
EUnetHTA JA Stakeholder Involvement Standard Operating Procedures (SOP)
EUnetHTA JA Expert Involvement Standard Operating Procedures (SOP)
This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.
©2021 EUnetHTA All rights reserved.